HRT Financial’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

HRT Financial’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-163,968	Closed	-$1.28M	–	3727
2021 Q1	$1.28M	Buy	163,968 +16,828	+11%	+$168K	0.01%	918
2020 Q4	$1.36M	Buy	+147,140	New	+$1.28M	0.03%	479
2020 Q1	–	Sell	-19,948	Closed	-$37K	–	1478
2019 Q4	$37K	Buy	+19,948	New	+$33.2K	﹤0.01%	1081

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HRT Financial's SURF Position: Q2 2021 in Review

HRT Financial sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2021, closing a stake of 163,968 shares — an estimated $1.28M sold.

HRT Financial first reported a position in SURF in Q4 2019 and held it in 3 quarters. The position peaked at $1.36M in Q4 2020. 96 funds tracked by Wall St. Rank hold SURF as of Q2 2021.

HRT Financial reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
HRT Financial sold 163,968 Surface Oncology, Inc. Common Stock shares in Q2 2021, an estimated $1.28M.
HRT Financial first reported a position in Surface Oncology, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
HRT Financial's Surface Oncology, Inc. Common Stock position peaked at $1.36M in Q4 2020.
96 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.